Charles W. Bishop
71Patents
25h-index
32Co-inventors
88Inventor score
Filing activity: Feb 3, 1982 → Oct 11, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5795882A | Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations | Human Necessities | 61 | Expired |
| US4488651A | Clothes rack | Human Necessities | 60 | Expired |
| US5707980A | Method for treating and preventing secondary hyperparathyroidism | Human Necessities | 58 | Expired |
| US5602116A | Method for treating and preventing secondary hyperparathyroidism | Human Necessities | 53 | Expired |
| US6903083B2 | Stabilized hydroxyvitamin D | Human Necessities | 47 | Expired |
| US5403831A | Method of treating and preventing loss of bone mass using 1.alpha.-hydroxy-vitamin D.sub.2 | Human Necessities | 47 | Expired |
| US5869473A | Method for treating and preventing hyperparathyroidism | Human Necessities | 44 | Expired |
| US5861386A | Method for treating and preventing secondary hyperparathyroidism | Human Necessities | 43 | Expired |
| US5614513A | Oral 1.alpha.-hydroxyprevitamin D | Human Necessities | 43 | Expired |
| US6242434A | 24-hydroxyvitamin D, analogs and uses thereof | Chemistry; Metallurgy | 41 | Expired |
| US6376479B1 | Method for treating and preventing hyperparathyroidism | Human Necessities | 40 | Expired |
| US5529991A | Oral 1.alpha.-hydroxyprevitamin D | Human Necessities | 40 | Expired |
| US6147064A | Oral 1.alpha.-hydroxyprevitamin D in composition and method for treating psoriasis | Human Necessities | 37 | Expired |
| US6150346A | Method and composition for treating or preventing osteoporosis | Human Necessities | 37 | Expired |
| US5622941A | Oral 1 .alpha.-hydroxyprevitamin D | Human Necessities | 35 | Expired |
| US6133250A | Oral 1.alpha.-hydroxyprevitamin D in methods for increasing blood level of activated vitamin D | Human Necessities | 34 | Expired |
| USD347573S | Container | General | 32 | Expired |
| US6503893B2 | Method of treating hyperproliferative diseases using active vitamin D analogues | Human Necessities | 31 | Expired |
| US8207149B2 | Method for treating secondary hyperparathyroidism in CKD | Human Necessities | 31 | Active |
| US8361488B2 | Methods and compositions for controlled release oral dosage of a vitamin D compound | Human Necessities | 29 | Active |
| US8426391B2 | Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 | Human Necessities | 28 | Active |
| US6929797B2 | Targeted therapeutic delivery of vitamin D compounds | Performing Operations; Transporting | 27 | Expired |
| US7122530B2 | 24-hydroxyvitamin D, analogs and uses thereof | Chemistry; Metallurgy | 26 | Expired |
| US8906410B2 | Oral dosage form of 25-hydroxyvitamin D | Human Necessities | 25 | Active |
| US8778373B2 | Methods for controlled release oral dosage of a vitamin D compound | Human Necessities | 25 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.